Nephros Inc. Files 8-K on Financials
Ticker: NEPH · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | Aug 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: NEPH
TL;DR
NEPHROS filed an 8-K on Aug 7th detailing financial results. Check it out.
AI Summary
Nephros Inc. filed an 8-K on August 11, 2025, reporting on results of operations and financial condition as of August 7, 2025. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This filing provides investors with crucial updates on Nephros Inc.'s financial health and operational results, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing with no immediate indication of significant risk or negative events.
Key Players & Entities
- NEPHROS INC (company) — Registrant
- August 7, 2025 (date) — Date of earliest event reported
- August 11, 2025 (date) — Filing Date
- 380 Lackawanna Place, South Orange, New Jersey 07079 (address) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated August 7, 2025.
What is the exact name of the company filing this report?
The exact name of the company is NEPHROS, INC.
In which state was Nephros Inc. incorporated?
Nephros Inc. was incorporated in Delaware.
What is the principal business address of Nephros Inc.?
The principal executive offices are located at 380 Lackawanna Place, South Orange, New Jersey 07079.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-08-11 16:15:32
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value NEPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 233KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001641172-25-022978.txt ( ) — 448KB
- neph-20250807.xsd (EX-101.SCH) — 3KB
- neph-20250807_lab.xml (EX-101.LAB) — 33KB
- neph-20250807_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Nephros, Inc. Dated: August 11, 2025 By: /s/ Judy Krandel Judy Krandel Chief Financial Officer